KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,084,000 | -4.1% | 108,609 | +22.3% | 0.00% | 0.0% |
| Q1 2015 | $1,130,000 | -10.3% | 88,790 | -0.3% | 0.00% | 0.0% |
| Q4 2014 | $1,260,000 | +27.4% | 89,072 | +23.9% | 0.00% | 0.0% |
| Q3 2014 | $989,000 | -6.3% | 71,918 | +4.9% | 0.00% | 0.0% |
| Q2 2014 | $1,055,000 | -12.7% | 68,584 | -3.4% | 0.00% | 0.0% |
| Q1 2014 | $1,209,000 | +22.5% | 70,964 | -6.9% | 0.00% | 0.0% |
| Q4 2013 | $987,000 | +2.9% | 76,194 | -19.7% | 0.00% | 0.0% |
| Q3 2013 | $959,000 | +44.0% | 94,914 | +6.5% | 0.00% | 0.0% |
| Q2 2013 | $666,000 | – | 89,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |